TEMESTA Side Effects

6654173-0 | Bladder Tamponade, Haematuria, Platelet Disorder
on Mar 16, 2010 Female patient from SWITZERLAND , 74 years of age, was diagnosed with hypertension and was treated with Temesta (View Usage). Patient experienced the following unwanted or unexpected effects: bladder tamponade, haematuria, platelet disorder. Temesta dosage: . During the same period patient was treated with PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), DETRUSITOL (Once Daily) (View Detrusitol Review and Detrusitol Label ), ELTROXIN (View Eltroxin Review and Eltroxin Label ), PLENDIL (View Plendil Review and Plendil Label ). Patient was hospitalized.

6408149-9 | Ileus Paralytic
Patient was taking Temesta (View Usage). Patient had the following side effects: ileus paralytic on Oct 12, 2009 from AUSTRIA Additional patient health information: Female patient , 42 years of age, weighting 132.3 lb, was diagnosed with personality disorder (What is personality disorder?), depression (What is depression?), suicidal ideation and. Temesta dosage: 2,5 Mg, Daily Dose 10 Mg. During the same period patient was treated with CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), LAMICTAL (View Lamictal Review and Lamictal Label ), NOZINAN (25 Mg, Daily Dose 50 Mg) (View Nozinan Review and Nozinan Label ), RISPERDAL (View Risperdal Review and Risperdal Label ), EFFEXOR XR (37.5 Mg, Daily Dose 225 Mg) (View Effexor Xr Review and Effexor Xr Label ), SEROQUEL (200 Mg, Daily Dose 800 Mg) (View Seroquel Review and Seroquel Label ). Patient was hospitalized.

6337500-3 | Condition Aggravated, Faecaloma, Gastrointestinal Motility Disorder, Haemorrhoids, Hypoalbuminaemia, Inappropriate Antidiuretic Hormone Secretion, Malnutrition, Pain
Adverse event was reported on Aug 21, 2009 by a Female patient taking Temesta (View Usage) (Dosage: Since Long Time, 0.5 Mg Daily) was diagnosed with essential hypertension and. Location: SWITZERLAND , 90 years of age, After Temesta was administered, patient had the following side effects: condition aggravated, faecaloma, gastrointestinal motility disorder, haemorrhoids, hypoalbuminaemia, inappropriate antidiuretic hormone secretion, malnutrition, pain (What is pain?). During the same period patient was treated with NEXIUM (40 Mg Daily, Started At The Hospital) (View Nexium Review and Nexium Label ), NORVASC (5 Mg Daily, Started At The Hospital) (View Norvasc Review and Norvasc Label ), VOLTAREN (View Voltaren Review and Voltaren Label ), ZANIDIP (View Zanidip Review and Zanidip Label ), COZAAR (View Cozaar Review and Cozaar Label ), SCHERIPROCT (View Scheriproct Review and Scheriproct Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), LAXOBERON (View Laxoberon Review and Laxoberon Label ). Patient was hospitalized.

6071591-2 | Hypotension, Malaise, Palpitations, Supraventricular Tachycardia
on Jan 30, 2009 Female patient from SWITZERLAND , 20 years of age, weighting 97.00 lb, was diagnosed with depression (What is depression?), major depression and was treated with Temesta (View Usage). Patient experienced the following unwanted or unexpected effects: hypotension, malaise, palpitations, supraventricular tachycardia. Temesta dosage: . During the same period patient was treated with SEROQUEL (View Seroquel Review and Seroquel Label ), EFFEXOR (View Effexor Review and Effexor Label ). Patient was hospitalized.


5843327-9 | Cardio-respiratory Arrest, Circulatory Collapse, Epilepsy, Ischaemia
on Aug 07, 2008 Male patient from BELGIUM , weighting 211.6 lb, was diagnosed with metastases to liver and was treated with Temesta (View Usage). Patient had the following side effects: cardio-respiratory arrest, circulatory collapse, epilepsy (What is epilepsy?), ischaemia. Temesta dosage: 1 Mg. During the same period patient was treated with ASPIRIN (100 Mg) (View Aspirin Review and Aspirin Label ), ELOXATIN (Unk) (View Eloxatin Review and Eloxatin Label ), EFFEXOR (75 Mg) (View Effexor Review and Effexor Label ), INDAPAMIDE (1 Df) (View Indapamide Review and Indapamide Label ). Patient was hospitalized.

5317688-3 | Blood Creatinine Increased, Fall, Hyponatraemia, Orthostatic Hypotension
Patient was taking Temesta (View Usage). After Temesta was administered, patient had the following side effects: blood creatinine increased, fall (What is fall?), hyponatraemia, orthostatic hypotension on Apr 24, 2007 from FRANCE Additional patient health information: Male patient , 84 years of age, was diagnosed with anxiety (What is anxiety?), hypertension, arteritis, atrial fibrillation (What is atrial fibrillation?) and. Temesta dosage: 1 Mg, Qd. During the same period patient was treated with LASIX (20 Mg, Qd) (View Lasix Review and Lasix Label ), XATRAL (10 Mg, Qd) (View Xatral Review and Xatral Label ), CORDARONE (View Cordarone Review and Cordarone Label ), CREON (View Creon Review and Creon Label ), IMODIUM (View Imodium Review and Imodium Label ), MINISINTROM (View Minisintrom Review and Minisintrom Label ), ALDALIX (1 Df, Qd) (View Aldalix Review and Aldalix Label ), NISIS (View Nisis Review and Nisis Label ). Patient was hospitalized.

5305624-5 | Blood Glucose Increased, Coordination Abnormal, Fall, Parkinsonism
Adverse event was reported on Mar 28, 2007 by a Male patient taking Temesta (View Usage) (Dosage: 1 Mg Tid Po) . Location: FRANCE , 66 years of age, Patient experienced the following unwanted or unexpected effects: blood glucose increased, coordination abnormal, fall (What is fall?), parkinsonism. During the same period patient was treated with AVLOCARDYL (160 Mg Q Day Po) (View Avlocardyl Review and Avlocardyl Label ), FLUOXETINE (Df Po) (View Fluoxetine Review and Fluoxetine Label ), STILNOX /00914901/ (Df Q Day Po) (View Stilnox /00914901/ Review and Stilnox /00914901/ Label ), TERCIAN /00759301/ (25 Mg Bid Po) (View Tercian /00759301/ Review and Tercian /00759301/ Label ). Patient was hospitalized.

5304187-8 | Agranulocytosis, Neutropenia, Respiratory Tract Infection
on Apr 10, 2007 Male patient from FINLAND , 30 years of age, was diagnosed with schizophrenia and was treated with Temesta (View Usage). Patient had the following side effects: agranulocytosis, neutropenia, respiratory tract infection. Temesta dosage: 2 Mg/day. During the same period patient was treated with NEUROBION FORTE (View Neurobion Forte Review and Neurobion Forte Label ), KALCIPOS D (View Kalcipos-d Review and Kalcipos-d Label ), ZOPINOX (7.5 Mg When Needed) (View Zopinox Review and Zopinox Label ), ZYPREXA (View Zyprexa Review and Zyprexa Label ), KLAMATH WEED PREPARATION (View Klamath Weed Preparation Review and Klamath Weed Preparation Label ), CLOZAPINE (View Clozapine Review and Clozapine Label ). Patient was hospitalized.

5291391-0 | Abnormal Behaviour, Agitation, Dehydration, Delirium, Depressed Level Of Consciousness, Fluid Intake Reduced, Hallucination, Visual, Renal Failure, Restlessness
on Mar 16, 2007 Female patient from SWITZERLAND , 81 years of age, weighting 101.6 lb, was treated with Temesta (View Usage). After Temesta was administered, patient had the following side effects: abnormal behaviour, agitation, dehydration, delirium, depressed level of consciousness, fluid intake reduced, hallucination, visual, renal failure, restlessness. Temesta dosage: 2.5 Mg Q Day Po. During the same period patient was treated with ZYPREXA (15 Mg Bid Po) (View Zyprexa Review and Zyprexa Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

5291127-3 | Hypotension, Oxygen Saturation Decreased, Sedation
Patient was taking Temesta (View Usage). Patient experienced the following unwanted or unexpected effects: hypotension, oxygen saturation decreased, sedation on Mar 16, 2007 from SWITZERLAND Additional patient health information: Female patient , 30 years of age, . Temesta dosage: 2.5 Mg Q Day Po. During the same period patient was treated with ZYPREXA (10 Mg Once Im) (View Zyprexa Review and Zyprexa Label ). Patient was hospitalized.

5281234-3 | Bone Marrow Failure, Histiocytosis Haematophagic, Leukopenia, Neutropenia, White Blood Cell Count Increased
Adverse event was reported on Mar 07, 2007 by a Female patient taking Temesta (View Usage) (Dosage: 1 Mg Q Day Po) was diagnosed with depression (What is depression?) and. Location: FRANCE , 65 years of age, Patient had the following side effects: bone marrow failure, histiocytosis haematophagic, leukopenia, neutropenia, white blood cell count increased. During the same period patient was treated with EFFEXOR (Df Po) (View Effexor Review and Effexor Label ), ACUPAN (Df Iv) (View Acupan Review and Acupan Label ), NEXIUM (Df Po) (View Nexium Review and Nexium Label ), LOXEN (Df Po) (View Loxen Review and Loxen Label ), PERFALGAN (4mg Q Day Iv) (View Perfalgan Review and Perfalgan Label ). Patient was hospitalized.

5273350-7 | Hallucination, Paranoia
on Mar 02, 2007 Male patient from SWITZERLAND , 42 years of age, was diagnosed with epilepsy (What is epilepsy?) and was treated with Temesta (View Usage). After Temesta was administered, patient had the following side effects: hallucination, paranoia. Temesta dosage: 5 Mg Q Day Po. During the same period patient was treated with KEPPRA (500 Mg Bid Po) (View Keppra Review and Keppra Label ), LISINOPRIL (5 Mg Q Day Po) (View Lisinopril Review and Lisinopril Label ), BELOC /00376902/ (50 Mg Q Day Po) (View Beloc /00376902/ Review and Beloc /00376902/ Label ), DORMICUM /00634102/ (30 Mg Q Day Po) (View Dormicum /00634102/ Review and Dormicum /00634102/ Label ), PLAVIX (75 Mg Q Day Po) (View Plavix Review and Plavix Label ), PRAZINE /00049902/ (100 Mg Q Day Po) (View Prazine /00049902/ Review and Prazine /00049902/ Label ).

5273077-1 | Foetal Distress Syndrome, Foetal Growth Retardation, Oligohydramnios, Pregnancy, Premature Baby
on Feb 28, 2007 Female patient from SWITZERLAND , 38 years of age, was diagnosed with conduct disorder, depression (What is depression?), urticaria and was treated with Temesta (View Usage). Patient experienced the following unwanted or unexpected effects: foetal distress syndrome, foetal growth retardation, oligohydramnios, pregnancy (What is pregnancy?), premature baby. Temesta dosage: Df. During the same period patient was treated with FLUCTINE (20 Mg Bid Po) (View Fluctine Review and Fluctine Label ), ZYRTEC (10 Mg Q Day Po) (View Zyrtec Review and Zyrtec Label ).

5271885-4 | Dehydration, Dizziness, Hypotension, Oxygen Saturation Decreased, Sedation
Patient was taking Temesta (View Usage). Patient had the following side effects: dehydration, dizziness (What is dizziness?), hypotension, oxygen saturation decreased, sedation on Feb 28, 2007 from SWITZERLAND Additional patient health information: Female patient , 30 years of age, . Temesta dosage: 2.5 Mg Q;day;po. During the same period patient was treated with ZYPREXA (10 Mg Once;im) (View Zyprexa Review and Zyprexa Label ). Patient was hospitalized.

5237945-9 | Aggression, Alanine Aminotransferase Decreased, Amnesia, Aspartate Aminotransferase Decreased, Blood Alkaline Phosphatase Increased, Confusional State, Disorientation, Gait Disturbance, Gamma-glutamyltransferase Increased
Adverse event was reported on Jan 25, 2007 by a Male patient taking Temesta (View Usage) (Dosage: 7.5 Mg Q Day Unk) was diagnosed with aggression and. Location: SWITZERLAND , 41 years of age, After Temesta was administered, patient had the following side effects: aggression, alanine aminotransferase decreased, amnesia, aspartate aminotransferase decreased, blood alkaline phosphatase increased, confusional state, disorientation, gait disturbance, gamma-glutamyltransferase increased. During the same period patient was treated with PANTOZOL (40 Mg Q Day Po) (View Pantozol Review and Pantozol Label ), AKINETON (4 Mg Q Day Po) (View Akineton Review and Akineton Label ), CLOPIXOL /00876701/ (60 Mg Q Day Po) (View Clopixol /00876701/ Review and Clopixol /00876701/ Label ), LITHIUM CARBONATE (660 Mg Q Day Po) (View Lithium Carbonate Review and Lithium Carbonate Label ), SEROPRAM /00582602/ (20 Mg Q Day Po) (View Seropram /00582602/ Review and Seropram /00582602/ Label ), TEGRETOL (200 Mg Q Day Po) (View Tegretol Review and Tegretol Label ). Patient was hospitalized.

5236480-1 | Bacterial Infection, Cardiac Arrest, Coma, Completed Suicide, Haemorrhagic Anaemia, Hypoxia, Intentional Overdose, Livedo Reticularis, Lung Consolidation
on Jan 23, 2007 Male patient from FRANCE , 61 years of age, was treated with Temesta (View Usage). Patient experienced the following unwanted or unexpected effects: bacterial infection (What is bacterial infection?), cardiac arrest (What is cardiac arrest?), coma, completed suicide, haemorrhagic anaemia, hypoxia, intentional overdose, livedo reticularis, lung consolidation. Temesta dosage: Df Once Po. During the same period patient was treated with EFFEXOR (Df Once Po) (View Effexor Review and Effexor Label ), BROMAZEPAM (Df Once Po) (View Bromazepam Review and Bromazepam Label ), PAROXETINE HCL (Df Once Po) (View Paroxetine Hcl Review and Paroxetine Hcl Label ), MITOTANE (Df Once Po) (View Mitotane Review and Mitotane Label ), DAFALGAN (View Dafalgan Review and Dafalgan Label ), HEXAQUINE (View Hexaquine Review and Hexaquine Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), FLUDROCORTISONE (View Fludrocortisone Review and Fludrocortisone Label ). Patient was hospitalized.

5223634-3 | Fall, Hyponatraemia, Orthostatic Hypotension
on Jan 19, 2007 Male patient from FRANCE , 84 years of age, was diagnosed with anxiety (What is anxiety?), hypertension, arteritis, atrial fibrillation (What is atrial fibrillation?) and was treated with Temesta (View Usage). Patient had the following side effects: fall (What is fall?), hyponatraemia, orthostatic hypotension. Temesta dosage: 1 Mg, Qd. During the same period patient was treated with LASIX (20 Mg, Qd) (View Lasix Review and Lasix Label ), XATRAL (10 Mg, Qd) (View Xatral Review and Xatral Label ), CORDARONE (View Cordarone Review and Cordarone Label ), CREON (View Creon Review and Creon Label ), IMODIUM (View Imodium Review and Imodium Label ), MINISINTROM (View Minisintrom Review and Minisintrom Label ), ALDALIX (1 Df, Qd) (View Aldalix Review and Aldalix Label ), NISIS (View Nisis Review and Nisis Label ). Patient was hospitalized.

5223162-5 | Back Pain, Bone Pain, Chest Discomfort, Chest Pain, Nightmare, Sensation Of Pressure, Sensory Disturbance
Patient was taking Temesta (View Usage). After Temesta was administered, patient had the following side effects: back pain (What is back pain?), bone pain, chest discomfort, chest pain (What is chest pain?), nightmare, sensation of pressure, sensory disturbance on Jan 08, 2007 from SWITZERLAND Additional patient health information: Male patient , 41 years of age, . Temesta dosage: Df Prn Po. During the same period patient was treated with NEUPOGEN (Df Q Day Sc) (View Neupogen Review and Neupogen Label ), NAVOBAN (Df Prn Po) (View Navoban Review and Navoban Label ), PRIMPERAN /00041901/ (Df Prn Po) (View Primperan /00041901/ Review and Primperan /00041901/ Label ), FOTECORTIN /00016001/ (View Fotecortin /00016001/ Review and Fotecortin /00016001/ Label ), NEXIUM (View Nexium Review and Nexium Label ), ZYLORIC (View Zyloric Review and Zyloric Label ).

5196498-4 | Abortion Induced, Pregnancy
Adverse event was reported on Dec 11, 2006 by a Female patient taking Temesta (View Usage) (Dosage: Df) . Location: SWITZERLAND , 40 years of age, Patient experienced the following unwanted or unexpected effects: abortion induced, pregnancy (What is pregnancy?).

5089483-4 | Somnolence, Sopor, Suicide Attempt, Urinary Tract Infection
on Aug 04, 2006 Female patient from SWITZERLAND , 49 years of age, was treated with Temesta (View Usage). Patient had the following side effects: somnolence, sopor, suicide attempt, urinary tract infection (What is urinary tract infection?). Temesta dosage: 50 Mg Once Po. During the same period patient was treated with DEPAKENE (Df Once Po) (View Depakene Review and Depakene Label ). Patient was hospitalized.

5089449-4 | Anxiety, Chills, Condition Aggravated, Hallucination, Visual, Nocturia
on Aug 04, 2006 Male patient from SWITZERLAND , 62 years of age, was diagnosed with anxiety disorder, parkinson's disease (What is parkinson's disease?), urinary incontinence (What is urinary incontinence?) and was treated with Temesta (View Usage). After Temesta was administered, patient had the following side effects: anxiety (What is anxiety?), chills, condition aggravated, hallucination, visual, nocturia. Temesta dosage: 1 Df Prn Po. During the same period patient was treated with CHLORALDURAT (250 Mg Bid Po) (View Chloraldurat Review and Chloraldurat Label ), COMTAN (200 Mg 5xd Po) (View Comtan Review and Comtan Label ), DETRUSITOL /01350201/ (4 Mg Qd Po) (View Detrusitol /01350201/ Review and Detrusitol /01350201/ Label ), MADOPAR DR (Df Q Day Po) (View Madopar Dr Review and Madopar Dr Label ), MADOPAR LIQ 62.5 (1 Df Qd Po) (View Madopar Liq 62.5 Review and Madopar Liq 62.5 Label ), REQUIP (2 Mg Qid Po) (View Requip Review and Requip Label ). Patient was hospitalized.

5079260-2 | Abortion Induced, Foetal Disorder, Oligohydramnios, Pregnancy On Oral Contraceptive, Renal Hypertrophy, Unintended Pregnancy
Patient was taking Temesta (View Usage). Patient experienced the following unwanted or unexpected effects: abortion induced, foetal disorder, oligohydramnios, pregnancy on oral contraceptive, renal hypertrophy, unintended pregnancy on Jul 21, 2006 from FRANCE Additional patient health information: Female patient , 39 years of age, was diagnosed with anxiety (What is anxiety?), contraception, hypertension, hypothyroidism and. Temesta dosage: Df Po. During the same period patient was treated with ADEPAL (1 Tab Q Day Po) (View Adepal Review and Adepal Label ), ALPRAZOLAM (Df Po) (View Alprazolam Review and Alprazolam Label ), CATAPRESAN (Df Po) (View Catapresan Review and Catapresan Label ), FOSINOPRIL SODIUM (Df Po) (View Fosinopril Sodium Review and Fosinopril Sodium Label ), HYDROCHLOROTHIAZIDE (Df Po) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), LEVOTHYROXINE SODIUM (Df Po) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

5076284-6 | Gastrointestinal Hypermotility, Serotonin Syndrome, Sleep Disorder
Adverse event was reported on Jul 19, 2006 by a Male patient taking Temesta (View Usage) (Dosage: 2 Mg Q Day Po) was diagnosed with anxiety (What is anxiety?), depression (What is depression?) and. Location: SWITZERLAND , 52 years of age, Patient had the following side effects: gastrointestinal hypermotility, serotonin syndrome, sleep disorder (What is sleep disorder?). During the same period patient was treated with SERESTA (Df) (View Seresta Review and Seresta Label ). Patient was hospitalized.

5076042-2 | Respiratory Arrest
on Jul 19, 2006 Female patient from DENMARK , 73 years of age, was diagnosed with anxiety (What is anxiety?), dyspnoea, panic attack and was treated with Temesta (View Usage). After Temesta was administered, patient had the following side effects: respiratory arrest. Temesta dosage: 1 Mg Qd; Po. During the same period patient was treated with MORPHINE (View Morphine Review and Morphine Label ), BETA 2 AGONIST (View Beta-2 Agonist Review and Beta-2 Agonist Label ). Patient was hospitalized.

5066126-7 | Blood Pressure Diastolic Increased, Blood Pressure Systolic Increased, Gastrooesophageal Reflux Disease, Hiccups, Tachycardia, Vomiting
on Jul 07, 2006 Male patient from SWITZERLAND , 43 years of age, was treated with Temesta (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure diastolic increased, blood pressure systolic increased, gastrooesophageal reflux disease, hiccups, tachycardia, vomiting. Temesta dosage: 3.5 Mg Qd Po. During the same period patient was treated with STILNOX (10 Mg Qd Po) (View Stilnox Review and Stilnox Label ), NOVALGIN (View Novalgin Review and Novalgin Label ), METHADONE HCL (View Methadone Hcl Review and Methadone Hcl Label ), PROMAZINE HYDROCHLORIDE (View Promazine Hydrochloride Review and Promazine Hydrochloride Label ), METAMIZOLE (View Metamizole Review and Metamizole Label ).

5058460-1 | International Normalised Ratio Increased, Urinary Bladder Haemorrhage, Urinary Retention
Patient was taking Temesta (View Usage). Patient had the following side effects: international normalised ratio increased, urinary bladder haemorrhage, urinary retention on Jul 04, 2006 from FRANCE Additional patient health information: Male patient , 84 years of age, . Temesta dosage: 1 Mg Q Day Po. During the same period patient was treated with EUPANTOL (40 Mg Q Day Po) (View Eupantol Review and Eupantol Label ), HEMIGOXINE NATIVELLE (0.125 Mg Q Day Po) (View Hemigoxine Nativelle Review and Hemigoxine Nativelle Label ), GLUCOR (View Glucor Review and Glucor Label ), NOVONORM (View Novonorm Review and Novonorm Label ), NORSET (View Norset Review and Norset Label ). Patient was hospitalized.

5042667-3 | Affect Lability, Confusional State, Delirium, Depressed Level Of Consciousness, Disturbance In Attention, Hypocalcaemia, Memory Impairment, Negativism
Adverse event was reported on Jun 07, 2006 by a Female patient taking Temesta (View Usage) (Dosage: 2.5 Mg Q Day Po) . Location: SWITZERLAND , 57 years of age, After Temesta was administered, patient had the following side effects: affect lability, confusional state, delirium, depressed level of consciousness, disturbance in attention, hypocalcaemia, memory impairment, negativism. During the same period patient was treated with DEANXIT (Df Q Day Po) (View Deanxit Review and Deanxit Label ), EFFEXOR (View Effexor Review and Effexor Label ), REMERON (View Remeron Review and Remeron Label ), NORTRIPTYLINE HCL (View Nortriptyline Hcl Review and Nortriptyline Hcl Label ), IMMOVANE (View Immovane Review and Immovane Label ), EUTHYROX (View Euthyrox Review and Euthyrox Label ). Patient was hospitalized.

5036543-X | Blood Pressure Decreased, Circulatory Collapse, Coma, Suicide Attempt
on Jun 09, 2006 Male patient from FRANCE , 40 years of age, was treated with Temesta (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure decreased, circulatory collapse, coma, suicide attempt. Temesta dosage: 20 Tab Once Po. During the same period patient was treated with AVLOCARDYL (1 G Once Po) (View Avlocardyl Review and Avlocardyl Label ), THERALEN (Df Unk Po) (View Theralen Review and Theralen Label ), XANAX (7.5 Mg Once Po) (View Xanax Review and Xanax Label ). Patient was hospitalized.

5035571-8 | Asthenia, Fluid Intake Reduced, Hypotension, Left Ventricular Failure, Mobility Decreased, Steal Syndrome, Vascular Encephalopathy
on Jun 06, 2006 Male patient from SWITZERLAND , 75 years of age, was treated with Temesta (View Usage). Patient had the following side effects: asthenia, fluid intake reduced, hypotension, left ventricular failure, mobility decreased, steal syndrome, vascular encephalopathy. Temesta dosage: 0.5 Mg Qd Po. During the same period patient was treated with PAROXETINE HCL (10 Mg Qd Po) (View Paroxetine Hcl Review and Paroxetine Hcl Label ), ZYPREXA (5 Mg Qd Po) (View Zyprexa Review and Zyprexa Label ). Patient was hospitalized.

5028195-X | Aggression, Priapism, Sedation
Patient was taking Temesta (View Usage). After Temesta was administered, patient had the following side effects: aggression, priapism, sedation on May 26, 2006 from SWITZERLAND Additional patient health information: Male patient , 50 years of age, was diagnosed with aggression and. Temesta dosage: 3.5 Mg Per 24hr. During the same period patient was treated with CLOPIXOL (DECANOATE) (90 Mg Per 24hr Po) (View Clopixol (decanoate) Review and Clopixol (decanoate) Label ), PRAZINE (200 Mg Per24hr Po) (View Prazine Review and Prazine Label ), ATENOLOL AND CHLORTHALIDONE (View Atenolol And Chlorthalidone Review and Atenolol And Chlorthalidone Label ). Patient was hospitalized.

5024913-5 | Delirium, Rash
Adverse event was reported on May 22, 2006 by a Male patient taking Temesta (View Usage) (Dosage: 4.5 Mg) was diagnosed with bipolar i disorder and. Location: AUSTRIA , 44 years of age, Patient experienced the following unwanted or unexpected effects: delirium, rash (What is rash?). During the same period patient was treated with LAMICTAL (25 Mg) (View Lamictal Review and Lamictal Label ), ALNA (View Alna Review and Alna Label ), CLOZAPINE (300 Mg) (View Clozapine Review and Clozapine Label ). Patient was hospitalized.

5024891-9 | Hepatic Steatosis, Hepatocellular Damage, Hypertriglyceridaemia
on May 22, 2006 Female patient from AUSTRIA , 22 years of age, was diagnosed with schizophrenia, undifferentiated type and was treated with Temesta (View Usage). Patient had the following side effects: hepatic steatosis, hepatocellular damage, hypertriglyceridaemia. Temesta dosage: 5 Mg. During the same period patient was treated with GEWALCAM (View Gewalcam Review and Gewalcam Label ), MIRTAZAPINE (30 Mg) (View Mirtazapine Review and Mirtazapine Label ), RISPERDAL (4 Mg) (View Risperdal Review and Risperdal Label ). Patient was hospitalized.

5009934-0 | Anxiety, Chills, Condition Aggravated, Hallucination, Visual
on May 05, 2006 Male patient from SWITZERLAND , 62 years of age, was diagnosed with anxiety disorder, parkinson's disease (What is parkinson's disease?), urinary incontinence (What is urinary incontinence?), hallucination and was treated with Temesta (View Usage). After Temesta was administered, patient had the following side effects: anxiety (What is anxiety?), chills, condition aggravated, hallucination, visual. Temesta dosage: 1 Df Prn Po. During the same period patient was treated with CHLORALDURAT (250 Mg Bid Po) (View Chloraldurat Review and Chloraldurat Label ), COMTAN (200 Mg 5xd Po) (View Comtan Review and Comtan Label ), DETRUSITOL /01350201/ (4 Mg Qd Po) (View Detrusitol /01350201/ Review and Detrusitol /01350201/ Label ), MADOPAR DR (1 Df 5xd Po) (View Madopar Dr Review and Madopar Dr Label ), MADOPAR LIQ 62.5 (1 Df Qd Po) (View Madopar Liq 62.5 Review and Madopar Liq 62.5 Label ), REQUIP (2 Mg Qid Po) (View Requip Review and Requip Label ), SEROQUEL (150 Mg Qd Po) (View Seroquel Review and Seroquel Label ).

4994346-6 | Encopresis, Enuresis, Gastrointestinal Malformation
Patient was taking Temesta (View Usage). Patient experienced the following unwanted or unexpected effects: encopresis, enuresis, gastrointestinal malformation on Apr 17, 2006 from SWITZERLAND Additional patient health information: Female patient , child 4 years of age, . Temesta dosage: Df Tran-p.

4960313-1 | Anaemia, Blood Pressure Decreased, Bundle Branch Block, Dehydration, Nausea, Pallor, Syncope
Adverse event was reported on Mar 10, 2006 by a Female patient taking Temesta (View Usage) (Dosage: 1 Mg Q Day Po) . Location: SWITZERLAND , 50 years of age, Patient had the following side effects: anaemia, blood pressure decreased, bundle branch block, dehydration, nausea (What is nausea?), pallor, syncope. During the same period patient was treated with DIPIPERON (40 Mg Q Day Po) (View Dipiperon Review and Dipiperon Label ), ZYPREXA (30 Mg Q Day Po) (View Zyprexa Review and Zyprexa Label ), STILNOX (View Stilnox Review and Stilnox Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), VITARUBIN (View Vitarubin Review and Vitarubin Label ).

4960305-2 | Arrhythmia, Sleep Apnoea Syndrome
on Mar 10, 2006 Male patient from NETHERLANDS , 71 years of age, was diagnosed with insomnia and was treated with Temesta (View Usage). After Temesta was administered, patient had the following side effects: arrhythmia (What is arrhythmia?), sleep apnoea syndrome. Temesta dosage: Df Q Day Po. During the same period patient was treated with LORAZEPAM (Df Q Day Po) (View Lorazepam Review and Lorazepam Label ).

4957424-3 | Accidental Exposure, Fatigue, Poisoning Deliberate, Road Traffic Accident, Somnolence
on Mar 09, 2006 Male patient from FRANCE , 25 years of age, was treated with Temesta (View Usage). Patient experienced the following unwanted or unexpected effects: accidental exposure, fatigue, poisoning deliberate, road traffic accident, somnolence. Temesta dosage: Df Po.

4950271-8 | Confusional State, Coordination Abnormal, Dysarthria, Gait Disturbance
Patient was taking Temesta (View Usage). Patient had the following side effects: confusional state, coordination abnormal, dysarthria, gait disturbance on Feb 28, 2006 from SWITZERLAND Additional patient health information: Male patient , 48 years of age, was diagnosed with affective disorder and. Temesta dosage: 4 Mg Q Day Po. During the same period patient was treated with TEGRETOL (1000 Mg Once Po) (View Tegretol Review and Tegretol Label ), ZYPREXA (15 Mg Once Po) (View Zyprexa Review and Zyprexa Label ). Patient was hospitalized.

4938578-1 | Disease Recurrence, Incoherent, Incorrect Dose Administered, Somnolence
Adverse event was reported on Feb 16, 2006 by a Female patient taking Temesta (View Usage) (Dosage: 0.33 Mg Q Day Po) . Location: FRANCE , 72 years of age, After Temesta was administered, patient had the following side effects: disease recurrence, incoherent, incorrect dose administered, somnolence. During the same period patient was treated with AVLOCARDYL (Df Po) (View Avlocardyl Review and Avlocardyl Label ), ELIFLIXOR (Df Po) (View Eliflixor Review and Eliflixor Label ), DEDROGYL (View Dedrogyl Review and Dedrogyl Label ), EVISTA (View Evista Review and Evista Label ), LEVOTHYROX (View Levothyrox Review and Levothyrox Label ). Patient was hospitalized.

4929505-1 | Agitation, Anxiety, Bipolar I Disorder, Completed Suicide, Depressive Symptom, Feeling Abnormal, Injury Asphyxiation, Mutism, Sleep Disorder
on Feb 08, 2006 Male patient from SWITZERLAND , 72 years of age, was diagnosed with major depression and was treated with Temesta (View Usage). Patient experienced the following unwanted or unexpected effects: agitation, anxiety (What is anxiety?), bipolar i disorder, completed suicide, depressive symptom, feeling abnormal, injury asphyxiation, mutism, sleep disorder (What is sleep disorder?). Temesta dosage: 1 Mg Q Day Po. During the same period patient was treated with CIPRALEX /DEN/ (5 Mg Q Day Po) (View Cipralex /den/ Review and Cipralex /den/ Label ), CIPRALEX /DEN/ (10 Mg Q Day Po) (View Cipralex /den/ Review and Cipralex /den/ Label ).

4929391-X | Road Traffic Accident
on Feb 08, 2006 Female patient from SWITZERLAND , 56 years of age, was treated with Temesta (View Usage). Patient had the following side effects: road traffic accident. Temesta dosage: 1 Mg Q Day Po.

4899432-7 | Agitation, Atrial Fibrillation, Bundle Branch Block Left, Computerised Tomogram Abnormal, Condition Aggravated, Confusional State, Electrocardiogram T Wave Inversion, Electroencephalogram Abnormal
Patient was taking Temesta (View Usage). After Temesta was administered, patient had the following side effects: agitation, atrial fibrillation (What is atrial fibrillation?), bundle branch block left, computerised tomogram abnormal, condition aggravated, confusional state, electrocardiogram t wave inversion, electroencephalogram abnormal on Jan 17, 2006 from FRANCE Additional patient health information: Female patient , 81 years of age, was diagnosed with anxiety (What is anxiety?), hypertension, dysthymic disorder and. Temesta dosage: 1 Mg Q Day Po. During the same period patient was treated with LASILIX (Df Po) (View Lasilix Review and Lasilix Label ), PROZAC (Df Po) (View Prozac Review and Prozac Label ), TOPALGIC (Df Po) (View Topalgic Review and Topalgic Label ), ALDACTONE/POTASSIUM CANRENOATE (Df) (View Aldactone/potassium Canrenoate Review and Aldactone/potassium Canrenoate Label ), LEXOMIL (Df Po) (View Lexomil Review and Lexomil Label ), MOPRAL (View Mopral Review and Mopral Label ), DIFFU K (View Diffu K Review and Diffu K Label ). Patient was hospitalized.

4899426-1 | Confusional State, Gastric Ulcer, Gastrointestinal Haemorrhage, Malaise, Overdose
Adverse event was reported on Jan 17, 2006 by a Female patient taking Temesta (View Usage) (Dosage: 1 Mg Q Day Po) was diagnosed with gastric ulcer and. Location: FRANCE , 95 years of age, Patient experienced the following unwanted or unexpected effects: confusional state, gastric ulcer, gastrointestinal haemorrhage, malaise, overdose. During the same period patient was treated with INIPOMP (Df Iv) (View Inipomp Review and Inipomp Label ). Patient was hospitalized.

4897228-3 | Alcohol Use
on Jan 13, 2006 Female patient from FRANCE , 22 years of age, was treated with Temesta (View Usage). Patient had the following side effects: alcohol use. Temesta dosage: 100 Mg Once Po. During the same period patient was treated with MEPRONIZINE (4 Tab Once Po) (View Mepronizine Review and Mepronizine Label ), ALCOHOL (Df Unk Po) (View Alcohol Review and Alcohol Label ), ABILIFY (1 Tab Q Day Po) (View Abilify Review and Abilify Label ), DEPAMIDE (3 Tab Q Day Po) (View Depamide Review and Depamide Label ), LEPTICUR (20 Mg Q Day Po) (View Lepticur Review and Lepticur Label ).

4892122-6 | Confusional State, Coordination Abnormal, Dysarthria, Gait Disturbance
on Jan 06, 2006 Male patient from SWITZERLAND , 48 years of age, was diagnosed with affective disorder and was treated with Temesta (View Usage). After Temesta was administered, patient had the following side effects: confusional state, coordination abnormal, dysarthria, gait disturbance. Temesta dosage: 4 Mg Q Day, Po. During the same period patient was treated with TEGRETOL (1000 Mg Once, Po) (View Tegretol Review and Tegretol Label ), ZYPREXA (15 Mg Once, Po) (View Zyprexa Review and Zyprexa Label ). Patient was hospitalized.

4892121-4 | Balance Disorder, Depressed Level Of Consciousness, Disorientation, Dry Mouth, Dysarthria, Dyskinesia, Intentional Overdose, Mydriasis, Urinary Incontinence
Patient was taking Temesta (View Usage). Patient experienced the following unwanted or unexpected effects: balance disorder, depressed level of consciousness, disorientation, dry mouth, dysarthria, dyskinesia, intentional overdose, mydriasis, urinary incontinence (What is urinary incontinence?) on Jan 06, 2006 from SWITZERLAND Additional patient health information: Female patient , 17 years of age, was diagnosed with eating disorder (What is eating disorder?) and. Temesta dosage: Df Once, Po. During the same period patient was treated with FLUCTINE (Df Q Day, Po) (View Fluctine Review and Fluctine Label ), ZYPREXA (12.5 Mg Once, Po) (View Zyprexa Review and Zyprexa Label ). Patient was hospitalized.

4887436-X | Acute Respiratory Distress Syndrome, Disturbance In Attention, Laryngospasm, Miosis, Tongue Spasm
Adverse event was reported on Jan 03, 2006 by a Male patient taking Temesta (View Usage) (Dosage: Df Po) was diagnosed with psychotic disorder (What is psychotic disorder?) and. Location: FRANCE , 40 years of age, Patient had the following side effects: acute respiratory distress syndrome, disturbance in attention, laryngospasm, miosis, tongue spasm. During the same period patient was treated with CLOPIXOL (DECANOATE) (Df Po) (View Clopixol (decanoate) Review and Clopixol (decanoate) Label ), CLOPIXOL SLOW RELEASE (Df Im) (View Clopixol - Slow Release Review and Clopixol - Slow Release Label ), STILNOX (Df Po) (View Stilnox Review and Stilnox Label ), TERCIAN (Df Po) (View Tercian Review and Tercian Label ), TRIHEXYPHENIDYL HCL (Df Po) (View Trihexyphenidyl Hcl Review and Trihexyphenidyl Hcl Label ).

4879583-3 | Alcohol Use
on Dec 29, 2005 Female patient from FRANCE , 22 years of age, was treated with Temesta (View Usage). After Temesta was administered, patient had the following side effects: alcohol use. Temesta dosage: 100 Mg Once Po. During the same period patient was treated with MEPRONIZINE (4 Tab Once Po) (View Mepronizine Review and Mepronizine Label ), ALCOHOL (Df Po) (View Alcohol Review and Alcohol Label ).

4867923-0 | Abortion Spontaneous
on Dec 13, 2005 Female patient from FRANCE , 37 years of age, was diagnosed with bipolar i disorder, mania, anaemia and was treated with Temesta (View Usage). Patient experienced the following unwanted or unexpected effects: abortion spontaneous. Temesta dosage: 4 Mg Q Day Po. During the same period patient was treated with CLOPIXOL (DECANOATE) (Df Once Im) (View Clopixol (decanoate) Review and Clopixol (decanoate) Label ), DEPAKOTE (1 G Q Day Po) (View Depakote Review and Depakote Label ), SPECIAFOLDINE (5 Mg Q Day Po) (View Speciafoldine Review and Speciafoldine Label ), ZYPREXA (2 Tab Q Day Po) (View Zyprexa Review and Zyprexa Label ). Patient was hospitalized.

4867080-0 | Abortion Induced
Patient was taking Temesta (View Usage). Patient had the following side effects: abortion induced on Dec 07, 2005 from SWITZERLAND Additional patient health information: Female patient , 29 years of age, was diagnosed with depression (What is depression?) and. Temesta dosage: 1 Mg Q Day Sl. During the same period patient was treated with FLUCTINE (20 Mg Q Day Po) (View Fluctine Review and Fluctine Label ), LEXOTANIL (2.5 Mg Q Day Po) (View Lexotanil Review and Lexotanil Label ), ZOLPIDEM TARTRATE (10 Mg Q Day Po) (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ), TRANXILIUM (5 Mg Bid Po) (View Tranxilium Review and Tranxilium Label ), ALCOHOL (View Alcohol Review and Alcohol Label ).